This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neu...
Evidence-based recommendations on regorafenib (Stivarga) for previously treated metastatic colorectal cancer in adults.
Commercial arrangement
There is a simple discount patient access scheme for regorafenib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS or...
Evidence-based recommendations on nivolumab (Opdivo) with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma.
Commercial arrangement
There is a commercial arrangement for nivolumab. NHS organisations can get...
Evidence-based recommendations on trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments in adults.
Commercial arrangement
There is a managed access agreement, which includes a patient access scheme, for trastuzumab derux...
Non-small cell lung cancer (NSCLC) is a heterogeneous disease accounting for approximately 85% of all lung cancers. Only 17% of patients are diagnosed at an early stage. Treatment is multidisciplinary and radiotherapy plays a key role in all stages of the disease. More than 50% of patients with NSCLC are...
This guideline covers diagnosing, monitoring and managing any type of primary brain tumour or
brain metastases in people aged 16 or over. It aims to improve diagnosis and care, including
standardising the care people have, how information and support are provided, and palliative care.
In January 2021, we...
La incidencia del carcinoma de células renales (CCR) ha aumentado en las últimas décadas, siendo a nivel mundial
el sexto cáncer más frecuentemente diagnosticado en hombres y el décimo en mujeres (1). Sin embargo, la
sobrevida ha mejorado en las últimas tres décadas. Esto se ha dado, en parte, po...
This guideline covers diagnosing, monitoring and managing any type of primary brain tumour or brain metastases in people aged 16 or over. It aims to improve diagnosis and care, including standardising the care people have, how information and support are provided, and palliative care....
El objetivo principal de esta Guía es recoger recomendaciones para el diagnóstico y el tratamiento de mujeres con cáncer de mama metastásico....
Breast Neoplasms/diagnosis,
Breast Neoplasms/therapy,
Neoplasm Metastasis,
Trastuzumab/therapeutic use,
Tamoxifen/therapeutic use,
Goserelin/therapeutic use,
Aromatase Inhibitors/therapeutic use,
Everolimus/therapeutic use,
Positron-Emission Tomography/methods,
Positron Emission Tomography Computed Tomography/methods,
Bone Neoplasms/secondary,
Biopsy,
GRADE Approach,
Antineoplastic Agents/administration & dosage
